Evidence map›Paper›PMID 34771506›Full record

ArticleCancers2021

Tonsillar Cancer with High CD8

David Gomez Jimenez, Aastha Sobti, David Askmyr, Christina Sakellariou, Sofia Carreira Santos, Sabine Swoboda, Ola Forslund, Lennart Greiff, Malin Lindstedt

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Targeted spatial proteomic analysis of CD8Frontiers in oncology · 2023
    Article
  5. Article
  6. Single-cell analysis of myeloid cells in HPVFrontiers in immunology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

David Gomez JimenezDepartment of Immunotechnology, Lund University, 223 81 Lund, Sweden.
Aastha SobtiDepartment of Immunotechnology, Lund University, 223 81 Lund, Sweden.
David AskmyrDepartment of ORL, Head & Neck Surgery, Skåne University Hospital, 221 85 Lund, Sweden.ORCID 0000-0003-1312-8524
Christina SakellariouDepartment of Immunotechnology, Lund University, 223 81 Lund, Sweden.
Sofia Carreira SantosDepartment of Immunotechnology, Lund University, 223 81 Lund, Sweden.
Sabine SwobodaDepartment of ORL, Head & Neck Surgery, Skåne University Hospital, 221 85 Lund, Sweden.
Ola ForslundDepartment of Microbiology, Lund University, 221 85 Lund, Sweden.
Lennart GreiffDepartment of ORL, Head & Neck Surgery, Skåne University Hospital, 221 85 Lund, Sweden.
Malin LindstedtDepartment of Immunotechnology, Lund University, 223 81 Lund, Sweden.
Lund University · SE

Funding

ACTA Oto-Laryngologica Foundation No grant numberCancera Foundation No grant numberFaculty of Engineering, Lund University No grant numberGovernmental funding 12711Henning and Ida Persson's Research Foundation No grant numberHorizon 2020 Framework Programme EU-H2020-MSCA-COFUND-2016-754299Laryngfonden 40-16SUS foundations and donations 85210
6 · The paper itself

Abstract

Human papillomavirus (HPV) is the main causal agent of tonsillar cancer (TC) and HPV

Indexed as

CD8+ T-cellsdendritic cellshuman papillomavirusmacrophagestonsillar cancertumor microenvironment

Identifiers

PMID34771506
PMCPMC8582523
OpenAlexW3209143747

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.